Susquehanna International Group
STRO icon

Susquehanna International Group’s Sutro Biopharma STRO Stock Holding History

Susquehanna International Group’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.11M Buy
+84,902
New +$1.53M ﹤0.01% 6055
2025
Q4 		– Sell
-10,359
Closed -$90K – 13579
2025
Q3 		$90K Sell
10,359
-14,162
-58% -$121K ﹤0.01% 11632
2025
Q2 		$175K Buy
24,521
+14,287
+140% +$117K ﹤0.01% 11350
2025
Q1 		$66.6K Buy
10,234
+2,887
+39% +$45.5K ﹤0.01% 11759
2024
Q4 		$135K Sell
7,347
-892
-11% -$27.2K ﹤0.01% 11099
2024
Q3 		$285K Buy
8,239
+1,986
+32% +$77.8K ﹤0.01% 9704
2024
Q2 		$183K Buy
6,253
+1,249
+25% +$49.4K ﹤0.01% 10486
2024
Q1 		$283K Buy
5,004
+1,280
+34% +$56.5K ﹤0.01% 9832
2023
Q4 		$160K Sell
3,724
-8,317
-69% -$264K ﹤0.01% 10910
2023
Q3 		$418K Sell
12,041
-1,457
-11% -$63.5K ﹤0.01% 8649
2023
Q2 		$628K Sell
13,498
-2,286
-14% -$114K ﹤0.01% 7777
2023
Q1 		$729K Buy
+15,784
New +$1M ﹤0.01% 7619
2022
Q4 		– Sell
-1,558
Closed -$86K – 13624
2022
Q3 		$86K Sell
1,558
-527
-25% -$31.2K ﹤0.01% 11820
2022
Q2 		$109K Sell
2,085
-2,205
-51% -$123K ﹤0.01% 11397
2022
Q1 		$353K Buy
4,290
+514
+14% +$48.9K ﹤0.01% 9870
2021
Q4 		$562K Buy
3,776
+838
+29% +$150K ﹤0.01% 8865
2021
Q3 		$555K Sell
2,938
-1,374
-32% -$261K ﹤0.01% 9109
2021
Q2 		$802K Sell
4,312
-2,346
-35% -$459K ﹤0.01% 8369
2021
Q1 		$1.51M Buy
+6,658
New +$1.58M ﹤0.01% 6616

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Susquehanna International Group's STRO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Sutro Biopharma (STRO) in Q1 2026: 84,902 shares worth $2.11M. The stake represents ﹤0.01% of the portfolio and ranks #6055 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in STRO as recently as Q3 2025.

Susquehanna International Group first reported a position in STRO in Q1 2021 and has held it in 19 quarters since. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Susquehanna International Group held 84,902 shares of Sutro Biopharma worth $2.11M as of Q1 2026.
  • Sutro Biopharma was a new Susquehanna International Group position in Q1 2026.
  • Sutro Biopharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6055 holding.
  • Susquehanna International Group first reported a position in Sutro Biopharma in Q1 2021 and has held it in 19 quarters since.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.